CRL

Charles River Laboratories International, Inc.

Healthcare›Medical - Diagnostics & Research|New York Stock Exchange|US

Price

$173.89

Market Cap

$8.56B

Beta

1.65

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-0.85%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+0.33%

P/E Ratio0.0

PEG Ratio—

FCF Yield+6.06%

Debt / Equity0.97

Interest Coverage4.0x

No credit card required

Already have an account? Sign in to view the full analysis for CRL.